CONTEXTVISION CONTX ACQUISITION OR DISPOSAL OF THE ISSUER'S OWN SHARES

ContextVision announces extended share buy-back programme

18. February 2026 kl. 16:50

The Board of Directors of ContextVision AB ("ContextVision" or "the Company") has resolved to extend the share buy-back programme announced on September 3, 2025, to be executed in accordance with the authorization granted to the Board of Directors by the Annual General Meeting of ContextVision held on 13 May 2025 ("the Authorization").

On February 18 2026, the Board of Directors of ContextVision approved an extension of the share buy-back programme announced on September 3, 2025. The terms of the extended programme remain unchanged and represent solely an extension of the existing programme until the Annual General Meeting (AGM) on 12 May 2026.

Transactions will be carried out through market purchases on the Oslo Stock Exchange, based on the authorization granted by the AGM held on 13 May 2025, and at prevailing market prices.

The maximum consideration of the programme is up to NOK 10,000,000, with a maximum of 4,000,000 shares.

The program will be terminated no later than May 11, 2026. ContextVision reserves the right to any time, suspend or terminate the programme, without prior notice. Shares purchased under the program will be used to reduce the number of outstanding shares and for other corporate purposes.

For further information, please contact: Richard Hallström, CFO Email: richard.hallstrom@contextvision.com About ContextVision ContextVision is a software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-02-18 16:50 CET.